The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

Published:2011-10 Issue:1 Volume:123 Page:13-18
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

King Erin R.,Zu Zhifei,Tsang Yvonne T.M.,Deavers Michael T.,Malpica Anais,Mok Samuel C.,Gershenson David M.,Wong Kwong-Kwok

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference32 articles.

1. Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas;Woo;Int J Gynecol Cancer,2008

2. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary;Bonome;Cancer Res,2005

3. Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis;Shih;Am J Obstet Gynecol,2010

4. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory;Kurman;Am J Surg Pathol,2010

5. Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential;Crispens;Obstet Gynecol,2002

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular changes driving low-grade serous ovarian cancer and implications for treatment;International Journal of Gynecologic Cancer;2024-06-30

2. Oncogenic Pathways and Targeted Therapies in Ovarian Cancer;Biomolecules;2024-05-15

3. In Silico Approach to Molecular Profiling of the Transition from Ovarian Epithelial Cells to Low-Grade Serous Ovarian Tumors for Targeted Therapeutic Insights;Current Issues in Molecular Biology;2024-02-26

4. Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins;International Journal of Molecular Sciences;2023-12-25

5. The Molecular Classification of Ovarian Cancer and Implication for Treatment;Essentials of Diagnostic Gynecological Pathology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3